Larotrectinib versus infigratinib for adult patients with both glioma and tyrosine kinase alterations after failure of initial therapies: Efficacy and safety analysis Yufang Chen; Jian Ma; Qianqian Gao; Yu Gai; Yichi Sun; Meihua Wang;

Effects of Apatinib combined with Temozolomide on levels of sPD-1 and sPD-L1 in patients with drug-resistant recurrent glioblastoma Ren Zhao Kuang; Jun Wang; Yuan Chuan Wang; Xiao Ping Tang;

Negative life events and depression by gender in the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil) Simone V. Silva; Itamar S. Santos; Danielle B. Lima; Alessandra C. Goulart; Ana C. Varella; Paulo A. Lotufo; Andre R. Brunoni; Isabela M. Bensenor;